Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol

The kinetics of oxidation of bis(maltolato)oxovanadium(IV), BMOV or VO(ma)(2), by dioxygen have been studied by UV-vis spectroscopy in both MeOH and H(2)O media. The VO(ma)(2):O(2) stoichiometry was 4:1. In aqueous solution, the pH-dependent rate of the VO(ma)(2)/O(2) reaction to generate cis-[VO(2)(ma)(2)](-) is attributed to the deprotonation of coordinated H(2)O, the deprotonated species [VO(ma)(2)(OH)](-) being more easily oxidized (k(OH) = 0.39 M(-)(1) s(-)(1), 25 degrees C) than the neutral form VO(ma)(2)(H(2)O) (k(H)()2(O) = 0.08 M(-)(1) s(-)(1), 25 degrees C). The activation parameters for the two second-order reactions in aqueous solution were deduced from variable temperature kinetic measurements. In MeOH, VO(ma)(2) was oxidized by dioxygen to cis-VO(OMe)(ma)(2), whose structure was characterized by single-crystal X-ray diffraction; the crystals were monoclinic, C2/c, with a = 28.103(1) ?, b = 7.721(2) ?, c = 13.443(2) ?, beta = 94.290(7) degrees, and Z = 8. The structure was solved by Patterson methods and was refined by full-matrix least-squares procedures to R = 0.043 for 1855 reflections with I >/= 3sigma(I). The kinetic results are consistent with a mechanism involving an attack of O(2) at the V(IV) center, followed by the formation of radicals and H(2)O(2) as transient intermediates.     

Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy

The structure and conformation of bis(acetylacetonato)oxovanadium(IV) [VO(acac)(2)] and bis(maltolato)oxovanadium(IV) [VO(malto)(2)] in frozen methanol have been determined by application of electron nuclear double resonance (ENDOR) spectroscopy. The positions of inner- and outer-sphere-coordinated solvent were assigned by ENDOR through use of selectively deuterated analogues of methanol. Similarly, the methyl and methylinyl proton resonance features of VO(acac)(2) were identified by site-selective deuteration. For VO(acac)(2), the ENDOR-determined metal-proton distances were best accounted for by a complex of tetragonal-pyramidal geometry, essentially identical to that determined by X-ray crystallography [Dodge, R. P.; Templeton, D. H.; Zalkin, A. J. Chem. Phys. 1961, 35, 55] but with an inner-sphere solvent molecule coordinated trans to the vanadyl oxygen and an axially positioned solvent molecule hydrogen-bonded to the vanadyl oxygen. In contrast to its trans conformation in crystals [Caravan, P.; et al. J. Am. Chem. Soc. 1995, 117, 12759], the VO(malto)(2) complex was found in a cis conformation whereby the donor oxygen atoms of one maltolato ligand occupied equatorial coordination sites. One of the donor oxygen atoms of the second maltolato ligand occupied the axial coordination site opposite the vanadyl oxygen atom, and the other an equatorial position. An inner-sphere-coordinated methanol molecule in the equatorial plane and a solvent molecule hydrogen-bonded to the vanadyl oxygen were also identified. No evidence for the trans isomer was observed.     

The effect of charged axial ligands on the EPR parameters in oxovanadium(IV) compounds: an unusual reduction of the Az (51V) values

Two series of octahedral oxovanadium(IV) compounds, containing charged or neutral axial ligands, with the tetradentate amidate molecules Hcapca and H2capcah of the general formulae trans-[V(IV)OX(capca)]0/+ (where X = Cl- (1.CH2Cl2), SCN- (2), N3 (3), CH3COO- (4), PhCOO- (5), imidazole (6. CH3NO2), and eta-nBuNH2 (7)) and cis-[V(VI)OX(Hcapcah)]0/+ (where X = Cl- (8.0.5CH2Cl2), SCN (9), N3 (10.2CH3OH), and imidazole (11)), were synthesized and characterized by X-ray crystallography (1.CH3OH,8.CHCl3, 9.2CH3CN, 10.CH3CN and cis-[VO(imidazole)(Hcapcah)+) and continuous-wave electron paramagnetic resonance (cw EPR) spectroscopy. In addition to the synthesis, crystallographic and EPR studies, the optical, infrared and magnetic properties (room temperature) of these compounds are reported. Ab initio calculations were also carried out on compound 8 CHCl3 and revealed that this isomer is more stable than the trans isomer, in good agreement with the experimental data. The cw EPR studies of compounds 1-5, that is, the V(IV)O2+ species containing monoanionic axial ligands, revealed a novel phenomenon of the reduction of their A, components by about 10% relative to the N4 reference compounds ([V(IV)O-(imidazole)4]2+ and [V(IV)O(2,2-bipyridine)2]2+). In marked contrast, such a reduction is not observed in compounds 6. CH3NO2-11, which contain neutral axial ligands. Based on the spin-Hamiltonian formalism a theoretical explanation is put forward according to which the observed reduction of Az is due to a reduction of the electron - nuclear dipolar coupling (P). The present findings bear strong relevance to cw EPR studies of oxovanadium(IV) in vanadoproteins, V(IV)O2+-substituted proteins, and in V(IV)O2+ model compounds, since the hyperfine coupling constant, Az, has been extensively used as a benchmark for identification of equatorial-donor-atom sets in oxovanadium(IV) complexes.     

Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers

Syntheses of vanadium complexes using the naturally occurring ligands isomaltol (Hima) and allomaltol (Hama), as well as a newly synthesized, potentially tetradentate diaminodipyrone [H(2)(en(ama)(2)], are reported. Complete characterization of the resulting compounds [trans-VO(ima)(2)(H(2)O), VO(ama)(2), V(ima)(3), V(ama)(3) and VO(en(ama)(2))], including X-ray crystallography analyses for trans-VO(ima)(2)(H(2)O) and V(ima)(3), are presented herein. Potentiometric titrations (25 degrees C, I = 0.16 M NaCl) were used to measure stability constants in the V(IV)-Hima system; these data were compared to previous data collected on the V(IV)-L (L = Hma, Hama) systems. The in vivo efficacy of these compounds to lower the blood glucose levels of STZ-diabetic rats was tested; all but VO(en(ama)(2)) produced significant decreases in plasma glucose levels. The results were compared to those of the benchmark compound BMOV [VO(ma)(2), bis(maltolato)oxovanadium(IV)], a known insulin-enhancing agent.     

Oxovanadium(IV) and -(V) complexes of dithiocarbazate-based tridentate Schiff base ligands: syntheses,structure, and photochemical reactivity of compounds involving imidazole derivatives as coligands

The tridentate dithiocarbazate-based Schiff base ligands H(2)L (S-methyl-3-((5-R-2-hydroxyphenyl)methyl)dithiocarbazate, R = NO(2), L = L(2); R = Br, L = L(3)) react with [VO(acac)(2)] in the presence of imidazole derivatives as coligands to form oxovanadium(IV) and cis-dioxovanadium(V) complexes. With benzimidazole and N-methylimidazole, the products are oxovanadium(IV) complexes, viz. [VOL(3)(BzIm)].0.5CH(3)CN (1a) and [VOL(N-MeIm)(2)] (L = L(3), 1b; L = L(2), 1c), respectively. In both 1a,b, the O and S donor atoms of the tridentate ligand are cis to the terminal oxo group (in the "equatorial" plane) and mutually trans, but the N donor atom is respectively cis and trans to the oxo atom, as revealed from X-ray crystallography. When imidazole or 4-methylimidazole is used as the ancillary ligand, the products obtained are water-soluble cis-dioxovanadium(V) complexes [VO(2)L(R'-ImH)] (L = L(3) and L(2), R' = H and Me, 2a-d). These compounds have zigzag chain structures in the solid state as confirmed by X-ray crystallographic investigations of 2a,d, involving an alternating array of LVO(2)(-) species and the imidazolium counterions held together by Coulombic interactions and strong hydrogen bonding. Complexes 2a-d are stable in water or methanol. In aprotic solvents, viz. CH(3)CN, DMF, or DMSO, however, they undergo photochemical transformation when exposed to visible light. The putative product is a mixed-oxidation divanadium(IV/V) species obtained by photoinduced reduction as established by EPR, electronic spectroscopy, and dynamic (1)H NMR experiments.     

Vanadium(V) complexes of a chelating dianionic [ONNO]-type amine bis(phenolate) ligand: synthesis and solid state and solution structures

The reaction between VO(OR)(3) (R = (i)()Pr, (t)()Bu, CH(2)CF(3)) and the chelating dianionic bis(phenoxy)amine ligand [ONNO]H(2) affords a mixture of two isomers (A and B in a ratio A:B approximately 3:1) formulated as VO(OR)[ONNO] (1a-c) (R = (i)()Pr (1a), (t)Bu (1b), CH(2)CF(3) (1c)). Multinuclear and NOESY NMR spectroscopy experiments were able to determine the structure in solution of the complexes. Both isomers have the symmetry-related phenolate groups in a trans configuration, the difference arising from the different configuration of the oxo and alkoxo ligands being located either cis (in isomer A) or trans (in isomer B) to the tripodal amino nitrogen donor atom and the (dimethylamino)ethyl sidearm respectively for the oxo and the alkoxo ligands. Crystals of isomer A (cis-1a) were obtained, and the structure determination confirms the arrangement of the ligands around the vanadium center. Analogue complexes VO(X)[ONNO] (X = Cl (2); X = N(3) (3)) were prepared by reacting equimolar amount of [ONNO]H(2) and VO(X)(n)(OR)(3-n) (X = Cl, R = Et, n = 1; X = N(3), R = (i)Pr, n = 2) at ambient temperature. Compounds 2 and 3 were further characterized by NMR spectroscopy experiments and X-ray structure determination. For both 2 and 3, a single isomer is obtained, having a trans-(O,O) configuration for the phenolate groups and a trans configuration of the oxo ligand in respect to the tripodal amino nitrogen donor atom. Finally, complex 2 could also be obtained by chlorination of 1a or 3 using a large excess of ClSiMe(3) in refluxing toluene.     

Mononuclear and mixed-valence binuclear oxovanadium complexes with benzimidazole-derived chelating agents

Oxovanadium complexes with H(2)bzimpy (2,6-bis[benzimidazol-2'-yl]pyridine) and Me(2)bzimpy (2,6-bis[N'-methylbenzimidazol-2'-yl]pyridine), and H(3)ntb (tris[benzimidazol-2'-yl-methyl]amine) and Me(3)ntb (tris[N'-methylbenzimidazol-2'-yl-methyl]amine) have been synthesized. Dioxovanadium(V) and oxovanadium(IV) complexes prepared from H(2)bzimpy and Me(2)bzimpy are [V(V)O(2)(Hbzimpy)].1.25H(2)O (1), [V(V)O(2)(Me(2)bzimpy)](ClO(4)).H(2)O (3), [V(IV)O(H(2)bzimpy)(H(2)O)(2)](CF(3)SO(3))(2).2H(2)O (2), and [V(IV)O(Me(2)bzimpy)(H(2)O)(2)](CF(3)SO(3))(2) (4). H(3)ntb and Me(3)ntb afforded oxovanadium(IV) complexes, [V(IV)O(Hntb)].2MeOH (5), [V(IV)O(H(3)ntb)Cl]Cl.H(2)O (7), [V(IV)O(Me(3)ntb)SO(4)].H(2)O (9), [V(IV)O(Me(3)ntb)Cl]Cl.H(2)O (10), and mixed-valence complexes, [(H(3)ntb)V(IV)O(mu-O)V(V)O(H(3)ntb)](CF(3)SO(3))(3).2H(2)O (8) and [(Me(3)ntb)V(IV)O(mu-O)V(V)O(Me(3)ntb)](CF(3)SO(3))(3).3H(2)O (11). Crystal structures of 2, 7, and 11 are reported. The mixed-valence complexes, 8 and 11, show 15-line isotropic ESR spectra in fluid solutions at room temperature. These compounds also exhibit an intervalence transfer band around 1015 nm which is essentially independent of solvent, so these compounds are stable, mixed-valence species where the single unpaired electron is delocalized over the two vanadium centers at ambient temperature. With respect to one-electron reduction, the dioxovanadium(V) complexes are redox-potential equivalent with their monooxovanadium(IV) counterparts.     

Coordination of BF(4)(-) to oxovanadium(V) complexes,evidenced by the redox potential of oxovanadium(IV/V) couples in CH(2)Cl(2)

The oxidation of oxovanadium(IV) complexes [LV(IV)O] (L = tetradentate Schiff-base ligands such as N,N'-ethylenebis(salicylideneaminate)(2-) (salen) and N,N'-2,2-dimethylpropylenebis(salicylideneaminate)(2-) (salpn)) to [LV(V)O](+), believed to be responsible for the voltammetric response near 0.6 V vs Ag/AgCl in CH(2)Cl(2) in the presence of tetrabutylammonium tetrafluoroborate as a supporting electrolyte, is in fact coupled to a homogeneous process where [LVO](+) coordinates BF(4)(-) to form a neutral complex formulated as [LVOBF(4)]. The formation constants for [VO(salen)BF(4)] and [VO(salpn)BF(4)] are evaluated to be K(salen)(-)(1) = 1.1 x 10(2) M(-)(1) and K(salpn)(-)(1) = 1.4 x 10 M(-)(1), respectively. Crystal structure of [VO(salen)BF(4)] reveals that one of the fluorine atoms in BF(4)(-) is so close to the vanadium(V) atom as to be practically bound in the solid state.     

Vibrational spectra of bis(maltolato)oxovanadium(IV): a potent insulin mimetic agent

The FTIR and FT-Raman spectra of the oxovanadium(IV) complex of 3-hydroxy-2-methyl-4-pyrone (maltol) bis(maltolato)oxovanadium(IV) were recorded and briefly discussed by comparison with the spectra of uncoordinated maltol and with some related species.     

Model Investigations for Vanadium-Protein Interactions. Synthetic, Structural, and Physical Studies of Vanadium(III) and Oxovanadium(IV/V) Complexes with Amidate Ligands

Reaction of the amide ligand N-[2-((2-pyridylmethylene)amino)phenyl]pyridine-2-carboxamide (Hcapca) with VCl(3) affords the compound trans-[VCl(2)(capca)] (1), the first example of a vanadium(III) complex containing a vanadium-deprotonated amide nitrogen bond, while reaction of bis(pentane-2,4-dionato)oxovanadium(IV) with the related ligands N-[2-((2-phenolylmethylene)amino)phenyl]pyridine-2-carboxamide (H(2)phepca), 1-(2-hydroxybenzamido)-2-(2-pyridinecarboxamido)benzene (H(3)hypyb), and 1,2-bis(2-hydroxybenzamido)benzene (H(4)hybeb) yields the complexes [VO(phepca)] (2), Na[VO(hypyb)].2CH(3)OH (4.2CH(3)OH), and Na(2)[VO(hybeb)].3CH(3)OH (5.3CH(3)OH) respectively. The preparation of the complex {N-[2-((2-thiophenoylmethylene)amino)phenyl]pyridine-2-carboxamido}oxovanadium(IV) (3) has been achieved by reaction of N-(2-aminophenyl)pyridine-2-carboxamide and 2-mercaptobenzaldehyde with [VO(CH(3)COO)(2)](x)(). Oxidation of complex 5.3CH(3)OH with silver nitrate gives its vanadium(V) analogue (8.CH(3)OH), which is readily converted to its corresponding tetraethylammonium salt (10.CH(2)Cl(2)) by a reaction with Et(4)NCl. The crystal structures of the octahedral 1.CH(3)CN, and the square-pyramidal complexes 3, 4.CH(3)CN, 5.2CH(3)OH, and 10 were demonstrated by X-ray diffraction analysis. Crystal data are as follows: 1.CH(3)CN, C(18)H(13)Cl(2)N(4)OV.CH(3)CN M(r) = 464.23, monoclinic, P2(1)/n, a = 10.5991(7) ?, b = 13.9981(7) ?, c = 14.4021(7) ?, beta = 98.649(2)(o), V = 2112.5(3) A(3), Z = 4, R = 0.0323, and R(w) 0.0335; 3, C(19)H(13)N(3)O(2)SV, M(r) = 398.34, monoclinic, P2(1)/n, a = 12.1108(10) ?, b = 19.4439(18) ?, c = 7.2351(7) ?, beta = 103.012(3) degrees, V = 1660.0(4) ?(3), Z = 4, R = 0.0355, and R(w) = 0.0376; 4.CH(3)CN, C(19)H(12)N(3)O(4)VNa.CH(3)CN, M(r) = 461.31, monoclinic, P2(1)/c, a = 11.528(1) ?, b = 11.209(1) ?, c = 16.512(2) ?, beta = 103.928(4)(o), V = 2071.0(5) ?(3), Z = 4, R = 0.0649, and R(w) = 0.0806; 5.2CH(3)OH, C(20)H(10)N(2)O(5)VNa(2).2CH(3)OH, M(r) = 519.31, triclinic, P1, a = 12.839(1) ?, b = 8.334(1) ?, c = 12.201(1) ?, alpha = 106.492(2) degrees, beta = 105.408(2) degrees, gamma = 73.465(2) degrees, V = 1175.6(3) ?(3), Z = 2, R = 0.0894, and R(w) = 0.1043; 10, C(28)H(32)N(3)O(5)V M(r) = 541.52, monoclinic, P2(1)/c, a = 11.711(3) ?, b = 18.554(5) ?, c = 12.335(3) ?, beta = 95.947(9) degrees, V = 2666(2) ?(3), Z = 4, R = 0.0904, and R(w) = 0.0879. In addition to the synthesis and crystallographic studies, we report the optical, infrared, magnetic, and electrochemical properties of these complexes. Electron paramagnetic resonance [of oxovanadium(IV) species] and (1)H, (13)C{(1)H}, and (51)V nuclear magnetic resonance [of oxovanadium(V) complex] properties are reported as well. This study represents the first systematic study of vanadium(III), V(IV)O(2+), and V(V)O(3+) species containing a vanadium-deprotonated amide nitrogen bond.     

Insulin-enhancing vanadium(III) complexes

Simple, high-yield, large-scale syntheses of the V(III) complexes tris(maltolato)vanadium(III), V(ma)3, tris(ethylmaltolato)vanadium(III), V(ema)3, tris(kojato)vanadium(III) monohydrate, V(koj)3-H2O, and tris(1,2-dimethyl-3-hydroxy-4-pyridinonato)vanadium(III) dodecahydrate, V(dpp)3-12H2O, are described; the characterization of these complexes by various methods and, in the case of V(dpp)3-12H2O, by an X-ray crystal structure determination, is reported. The ability of these complexes to normalize glucose levels in the STZ-diabetic rat model has been examined and compared with that of the benchmark compound BMOV (bis(maltolato)oxovanadium(IV)), an established insulin-enhancing agent.     

Interaction of vanadyl (VO2+) with ligands containing serine, tyrosine, and threonine

Reaction of vanadyl sulfate with an aldehyde (2-hydroxy-1-naphthaldehyde (nap); 3-methoxysalicylaldehyde = o-vanillin (van)) and an amino acid carrying an OH group (L-tyrosine (L-tyr); L-serine (L-ser), L-threonine (L-thr)) yielded the complexes [VO(nap-D-Tyr)(H2O)] 1a, [VO(van-D,L-Tyr)(H2O)] 1c, [VO(nap-Ser)(H2O)] 2a, [VO(van-D,L-Ser)(H2O)] 2b, [VO(nap-Thr)(H2O)] 3a, and [VO(van-Thr)(H2O)] 3b. [VO(nap-L-tyr(H2O)], 1b, was obtained from the reaction between [VO(nap)(2)] and l-TyrOMe. The crystal and molecular structures of 1a.CH3OH, 1b.CH3OH, 1c.H2O, 2b.2H2O, and the Schiff base nap-D,L-TyrOMe (4) are reported. The ligands coordinate in a tridentate manner through the phenolate component of nap or van, the imine nitrogen, and the carboxylate of the amino acid. Direct coordination of the (deprotonated) OH amino acid functionality is not observed in these complexes. Instead, the OH groups are involved in hydrogen bonding, leading, along with pi-pi stacking, to extended one- and three-dimensional supramolecular networks. The relevance for the interaction between oxovanadium(IV,V) and proteins having serine, threonine, or tyrosine at their reactive sites is addressed.     

Mononuclear oxovanadium complexes of tris(2-pyridylmethyl)amine

Mononuclear oxovanadium(IV) and dioxovanadium(V) complexes of tris(2-pyridylmethyl)amine (tpa) have been prepared for the first time. Crystal structure determinations of three oxovanadium(IV) complexes, [VO(SO4)(tpa)], [VOCl(tpa)]PF6, or [VOBr(tpa)]PF6, and a dioxovanadium(v) complex [V(O)2(tpa)]PF6 disclosed that the tertiary nitrogen of the tpa ligand always occupies the trans-to-oxo site. The structures of an oxo-peroxo complex [VO(O2)(tpa)]Cl that was prepared previously and of a mu-oxo vanadium(III) complex [{VCl(tpa)}2(mu-O)](PF6)2 have also been determined. The tertiary nitrogen is located at a trans site to the peroxo and chloride ligands, respectively. The total sums of the four V-N bond lengths from the tpa ligand are remarkably similar among the six complexes, indicating that the vanadium oxidation states become less influential in tpa bonding due primarily to the coordination of electron-donating oxo ligand(s). Absorption spectra of [VOCl(tpa)]+ in acetonitrile showed a significant change upon addition of p-toluenesulfonic acid and HClO4, but not on addition of benzoic acid. Protonation at the oxo ligand by the former two acids is suggested. Cyclic voltammetric studies in acetonitrile verified the proton-coupled redox behavior of the V(III)/V(IV) process involving the oxo ligand for the first time. From the dependence of the added p-toluenesulfonic acid to the CV, redox potentials for the following species have been estimated: [V(IV)OCl(tpa)]+/[V(III)OCl(tpa)](E1/2=-1.59 V vs. Fc+/Fc), [V(IV)(OH)Cl(tpa)]2+/[V(III)(OH)Cl(tpa)]+(Epc=-1.34 V), [V(IV)(OH2)Cl(tpa)]3+/[V(III)(OH2)Cl(tpa)]2+(Epa=-0.49 V), and [V(IV)Cl2(tpa)]2+/[V(III)Cl2(tpa)]+(E1/2=-0.89 V). The reduction of [V(V)(O)2(tpa)]+ in 0.05 M [(n-Bu)4N]PF6 acetonitrile showed a major irreversible reduction wave V(V)/(IV) at -1.48 V. The metal reduction potentials of the oxovanadium(IV) and dioxovanadium(V) species are very close, reinforcing the significant influence of the oxo ligand(s).     

Binuclear (salen)osmium phosphinidine and phosphiniminato complexes

The preparation of a number of binuclear (salen)osmium phosphinidine and phosphiniminato complexes using various strategies are described. Treatment of [Os(VI)(N)(L(1))(sol)](X) (sol = H(2)O or MeOH) with PPh(3) affords an osmium(IV) phosphinidine complex [Os(IV){N(H)PPh(3)}(L(1))(OMe)](X) (X = PF(6)1a, ClO(4)1b). If the reaction is carried out in CH(2)Cl(2) in the presence of excess pyrazine the osmium(III) phosphinidine species [Os(III){N(H)PPh(3)}(L(1))(pz)](PF(6)) 2 can be generated. On the other hand, if the reaction is carried out in CH(2)Cl(2) in the presence of a small amount of H(2)O, a μ-oxo osmium(IV) phosphinidine complex is obtained, [(L(1)){PPh(3)N(H)}Os(IV)-O-Os(IV){N(H)PPh(3)}(L(1))](PF(6))(2)3. Furthermore, if the reaction of [Os(VI)(N)(L(1))(OH(2))]PF(6) with PPh(3) is done in the presence of 2, the μ-pyrazine species, [(L(1)){PPh(3)N(H)}Os(III)-pz-Os(III){N(H)PPh(3)}(L(1))](PF(6))(2)4 can be isolated. Novel binuclear osmium(IV) complexes can be prepared by the use of a diphosphine ligand to attack two Os(VI)≡N. Reaction of [Os(VI)(N)(L(1))(OH(2))](PF(6)) with PPh(2)-C≡C-PPh(2) or PPh(2)-(CH(2))(3)-PPh(2) in MeOH affords the binuclear complexes [(MeO)(L(1))Os(IV){N(H)PPh(2)-R-PPh(2)N(H)}Os(IV)(L(1))(OMe)](PF(6))(2) (R = C≡C 5, (CH(2))(3)6). Reaction of [Os(VI)(N)(L(2))Cl] with PPh(2)FcPPh(2) generates a novel trimetallic complex, [Cl(L(2))Os(IV){NPPh(2)-Fc-PPh(2)N}Os(IV)(L(2))Cl] 7. The structures of 1b, 2, 3, 4, 5 and 7 have been determined by X-ray crystallography.     

Two novel heterometallic chains featuring Mn(II) and Na(I) ions in trigonal-prismatic geometries alternately linked to octahedral Mn(IV) ions: synthesis, structures, and magnetic behavior

Two new one-dimensional heterometallic complexes, [Mn(3)Na(L)(4)(CH(3)CO(2))(MeOH)(2)](ClO(4))(2)·3H(2)O (1), [Mn(3)Na(L)(4)(CH(3)CH(2)CO(2))(MeOH)(2)](ClO(4))(2)·2MeOH·H(2)O (2) [LH(2) = 2-methyl-2-(2-pyridyl)propane-1,3-diol], have been synthesized and characterized by X-ray crystallography. Both complexes feature Mn(II) and Na(I) ions in trigonal-prismatic geometries that are linked to octahedral Mn(IV) ions by alkoxy bridges. Variable-temperature direct- and alternating-current magnetic susceptibility data indicated a spin ground state of S = 11/2 for both complexes. Density functional theory calculations performed on 1 supported this conclusion.     

Monomeric oxovanadium(IV) compounds of the general formula cis-[V(IV)(=O)(X)(L(NN))(2)](+/0) [X = OH(-), Cl(-), SO(4)(2)(-) and L(NN) = 2,2'-bipyridine (bipy) or 4,4'-disubstituted bipy

Reaction of [V(IV)OCl(2)(THF)(2)] in aqueous solution with 2 equiv of AgBF(4) or AgSbF(6) and then with 2 equiv of 2,2'-bipyridine (bipy), 4,4'-di-tert-butyl-2,2'-bipyridine (4,4'-dtbipy), or 4,4'-di-methyl-2,2'-bipyridine (4,4'-dmbipy) affords compounds of the general formula cis-[V(IV)O(OH)(L(NN))(2)]Y [where L(NN) = bipy, Y = BF(4)(-) (1), L(NN) = 4,4'-dtbipy, Y = BF(4)(-) (2.1.2H(2)O), L(NN) = 4,4'-dmbipy, Y = BF(4)(-) (3.2H(2)O), and L(NN) = 4,4'-dtbipy, Y = SbF(6)(-) (4)]. Sequential addition of 1 equiv of Ba(ClO(4))(2) and then of 2 equiv of bipy to an aqueous solution containing 1 equiv of V(IV)OSO(4).5H(2)O yields cis-[V(IV)O(OH)(bipy)(2)]ClO(4) (5). The monomeric compounds 1-5 contain the cis-[V(IV)O(OH)](+) structural unit. Reaction of 1 equiv of V(IV)OSO(4).5H(2)O in water and of 1 equiv of [V(IV)OCl(2)(THF)(2)] in ethanol with 2 equiv of bipy gives the compounds cis-[V(IV)O(OSO(3))(bipy)(2)].CH(3)OH.1.5H(2)O (6.CH(3)OH.1.5H(2)O) and cis-[V(IV)OCl(bipy)(2)]Cl (7), respectively, while reaction of 1 equiv of [V(IV)OCl(2)(THF)(2)] in CH(2)Cl(2) with 2 equiv of 4,4'-dtbipy gives the compound cis-[V(IV)OCl(4,4'-dtbipy)(2)]Cl.0.5CH(2)Cl(2) (8.0.5CH(2)Cl(2)). Compounds cis-[V(IV)O(BF(4))(4,4'-dtbipy)(2)]BF(4) (9), cis-[V(IV)O(BF(4))(4,4'-dmbipy)(2)]BF(4) (10), and cis-[V(IV)O(SbF(6))(4,4'-dtbipy)(2)]SbF(6) (11) were synthesized by sequential addition of 2 equiv of 4,4'-dtbipy or 4,4'-dmbipy and 2 equiv of AgBF(4) or AgSbF(6) to a dichloromethane solution containing 1 equiv of [V(IV)OCl(2)(THF)(2)]. The crystal structures of 2.1.2H(2)O, 6.CH(3)OH.1.5H(2)O, and 8.0.5CH(2)Cl(2) were demonstrated by X-ray diffraction analysis. Crystal data are as follows: Compound 2.1.2H(2)O crystallizes in the orthorhombic space group Pbca with (at 298 K) a = 21.62(1) A, b = 13.33(1) A, c = 27.25(2) A, V = 7851(2) A(3), Z = 8. Compound 6.CH(3)OH.1.5H(2)O crystallizes in the monoclinic space group P2(1)/a with (at 298 K) a = 12.581(4) A, b = 14.204(5) A, c = 14.613(6) A, beta = 114.88(1) degrees, V = 2369(1), Z = 4. Compound 8.0.5CH(2)Cl(2) crystallizes in the orthorhombic space group Pca2(1) with (at 298 K) a = 23.072(2) A, b = 24.176(2) A, c = 13.676(1) A, V = 7628(2) A(3), Z = 8 with two crystallographically independent molecules per asymmetric unit. In addition to the synthesis and crystallographic studies, we report the optical, infrared, magnetic, conductivity, and CW EPR properties of these oxovanadium(IV) compounds as well as theoretical studies on [V(IV)O(bipy)(2)](2+) and [V(IV)OX(bipy)(2)](+/0) species (X = OH(-), SO(4)(2)(-), Cl(-)).     

Kinetics and mechanism of ligand substitution in bis(N-alkylsalicylaldiminato)oxovanadium(IV) complexes

Conventional and stopped-flow spectrophotometry was used to to study the kinetics of ligand substitution in a number of bis(N-alkylsalicylaldiminato)oxovanadium(IV) complexes (=VO(R-X-sal)(2)) by 1,1,1- trifluoropentane-2,4-dione (=Htfpd) in acetone, according to the following reaction: VO(R-X-sal)(2) + 2Htfpd --> VO(tfpd)(2) + 2R-X-salH. The acronym R-X-salH refers to N-alkylsalicylaldimines with substituents X = H, Cl, Br, CH(3), and NO(2) in the 5-position of the salicylaldehyde ring and N-alkyl groups R = n-propyl, isopropyl, phenyl, and neopentyl. Under excess conditions ([Htfpd](0) > [VO(R-X-sal)(2)](0)), substitution by Htfpd occurs in two observable steps, as characterized by pseudo-first-order rate constants k(obsd(1)) and k(obsd(2)). Both rate constants increase linearly with [Htfpd](0) according to k(obsd(1)) = k(s(1)) + k(1)[Htfpd](0) and k(obsd(2)) = k(s(2)) + k(2)[Htfpd](0), with k(s(1)) and k(s(2)) describing small contributions of solvent-initiated pathways. Depending on the nature of R and X, second-order rate constants k(1) and k(2) lie in the range 0.098-0.87 M(-1) s(-1) (k(1)) and 0.022-0.41 M(-1) s(-1) (k(2)) at 298 K. For ligand substitution in the system VO(n-propyl-sal)(2)/Htfpd, the activation parameters DeltaH++ = 35.8 +/- 2.8 kJ mol(-1) and DeltaS++ = -146 +/- 23 J K(-1) mol(-1) (k(1)) and DeltaH++ = 40.2 +/- 1.3 kJ mol(-1) and DeltaS++ = -142 +/- 11 J K(-1) mol(-1) (k(2)) were obtained. The Lewis acidity of the complexes VO(n-propyl-X-sal)(2) with X = H, Cl, Br, CH(3), and NO(2) was quantified spectrophotometrically by determination of equilibrium constant K(py), describing the formation of the adduct VO(n-propyl-X-sal)(2).pyridine. The adduct VO(tfpd)(2).n-propyl-salH, formed as product in the system VO(n-propyl-sal)(2)/Htfpd, was characterized by its dissociation constant, K(D) = (3.30 +/- 0.10) x 10(-3) M. The mechanism suggested for the two-step substitution process is based on initial formation of the adducts VO(R-X-sal)(2).Htfpd (step 1) and VO(R-X-sal)(tfpd).Htfpd (step 2).     

Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies

Four mixed O,S binding bidentate ligand precursors derived from maltol (3-hydroxy-2-methyl-4-pyrone) have been chelated to vanadium to yield new bis(ligand)oxovanadium(IV) and tris(ligand)vanadium(III) complexes. The four ligand precursors include two pyranthiones, 3-hydroxy-2-methyl-4-pyranthione, commonly known as thiomaltol (Htma), and 2-ethyl-3-hydroxy-4-pyranthione, commonly known as ethylthiomaltol (Hetma), as well as two pyridinethiones, 3-hydroxy-2-methyl-4(H)-pyridinethione (Hmppt) and 3-hydroxy-1,2-dimethyl-4-pyridinethione (Hdppt). Vanadium complex formation was confirmed by elemental analysis, mass spectrometry, and IR and EPR (where possible) spectroscopies. The X-ray structure of oxobis(thiomaltolato)vanadium(IV),VO(tma)(2), was also determined; both cis and trans isomers were isolated in the same asymmetric unit. In both isomers, the two thiomaltolato ligands are arranged around the base of the square pyramid with the V=O linkage perpendicular; the vanadium atom is slightly displaced from the basal plane [V(1) = 0.656(3) A, V(2) = 0.664(2) A]. All of the new complexes were screened for insulin-enhancing effectiveness in streptozotocin-induced diabetes in rats, and VO(tma)(2) was profiled metabolically for urinary vanadium and ligand clearance by GFAAS and ESIMS, respectively. The new vanadium complexes did not lower blood glucose levels acutely, possibly because of rapid dissociation and excretion.     

Synthesis, characterisation and catalytic potential of hydrazonato-vanadium(V) model complexes with [VO]3+ and [VO2]+ cores

Reaction between [VO(acac)2] and H2L (H2L are the hydrazones H2sal-nah I or H2sal-fah II; sal = salicylaldehyde, nah = nicotinic acid hydrazide and fah = 2-furoic acid hydrazide) in methanol leads to the formation of oxovanadium(IV) complexes [VOL.H2O](H2L = I: 1, H2L = II: 4). Aerial oxidation of the methanolic solutions of 1 and 4 yields the dinuclear oxo-bridged monooxovanadium(V) complexes [{VOL}2mu-O](H2L = I: 2, H2L = II: 5). These dinuclear complexes slowly convert, in excess methanol, to [VO(OMe)(MeOH)L](H(2)L = I: 9, H(2)L = II: 10), the crystal and molecular structures of which have been determined, confirming the ONO binding mode of the dianionic ligands in their enolate form. Reaction of aqueous K[VO3] with the ligands at pH ca. 7.5 results in the formation of [K(H2O)][VO2L](H2L = I: 3, H2L = II: 6). Treatment of 3 and 6 with H2O2 yields (unstable) oxoperoxovanadium(v) complexes K[VO(O2)L], the formation of which has been monitored spectrophotometrically. Acidification of methanolic solutions of 3 and 6 with HCl affords oxohydroxo complexes, while the neutral complexes [VO2(Hsal-nah)] 7 and [VO2(Hsal-fah)] 8 were isolated on treatment of aqueous solutions of 3 and 6 with HClO4. These complexes slowly transform into 9 and 10 in methanol, as confirmed by 1H, 13C and 51V NMR. The anionic complexes 3 and 6 catalyse the oxidative bromination of salicylaldehyde in water in the presence of H2O2/KBr to 5-bromosalicylaldehyde and 3,5-dibromosalicylaldehyde, a reaction similar to that exhibited by vanadate-dependent haloperoxidases. They are also catalytically active for the oxidation of benzene to phenol and phenol to catechol and p-hydroquinone.     

Structural models of vanadate-dependent haloperoxidases and their reactivity

Vanadium(V) complexes with hydrazone-based ONO and ONN donor ligands that partly model active-site structures of vanadate-dependent haloperoxidases have been reported. On reaction with [VO(acac)₂] (Hacac = acetylacetone) under nitrogen, these ligands generally provide oxovanadium(IV) complexes [VO(ONO)X] (X = solvent or nothing) and [VO(acac)(ONN)], respectively. Under aerobic conditions, these oxovanadium(IV) species undergo oxidation to give oxovanadium(V), dioxovanadium (V) or μ-oxobisoxovanadium(V) species depending upon the nature of the ligand. Anionic and neutral dioxovanadium(V) complexes slowly deoxygenate in methanol to give monooxo complexes [VO(OMe)(MeOH)(ONO)]. The anionic complexes [VO₂(ONO)]^- can also be convertedin situ on acidification to oxohydroxo complexes [VO(OH)(HONO)]⁺ and to peroxo complexes [VO(O₂)(ONO)]^-, and thus to the species assumed to be intermediates in the haloperoxidases activity of the enzymes. In the presence of catechol (H₂cat) and benzohydroxamic acid (H₂bha), oxovanadium (IV) complexes, [VO (acac)(ONN)] gave mixed-chelate oxovanadium(V) complexes [VO(cat)(ONN)] and [VO(bha)(ONN)] respectively. These complexes are not very stable in solution and slowly convert to the corresponding dioxo species [VO₂(ONN)] as observed by⁵¹V NMR and electronic absorption spectroscopic studies.